Endothelin-1 potentiation of coronary artery contraction after ischemia–reperfusion

Bauersachs, 2000, Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure, Cardiovasc. Res., 47, 142, 10.1016/S0008-6363(00)00083-3

De Clerk, 1990, 5-hydroxytryptamine and thromboxane A2 in ischemic heart disease, Blood Coagul. Fibrinolysis, 1, 201

Edwards, 1995, Effect of endothelin-1 on arterial response to Bay K 8644. A comparison of ischemic and nonischemic arteries, Life Sci., 57, 225, 10.1016/0024-3205(95)00267-A

Eskesen, 2006, Upregulation of endothelin ETB receptor-mediated vasoconstriction in rat coronary artery after organ culture, Eur. J. Pharmacol., 539, 192, 10.1016/j.ejphar.2006.04.024

Fernández, 2003, In vivo coronary effects of endothelin-1 after ischemia–reperfusion: role of nitric oxide and prostanoids, Eur. J. Pharmacol., 481, 109, 10.1016/j.ejphar.2003.09.012

García-Villalón, 1997, Role of endothelin receptors, calcium and nitric oxide in the potentiation by endothelin-1 of the sympathetic contraction of rabbit ear artery during cooling, Br. J. Pharmacol., 12, 1659, 10.1038/sj.bjp.0701324

García-Villalón, 1999, Basal inhibitory action of endogenous endothelin on the sympathetic contraction in the isolated rat tail artery, Eur. J. Pharmacol., 384, 163, 10.1016/S0014-2999(99)00687-1

García-Villalón, 2000, Impaired potentiation by endothelin-1 and vasopressin of sympathetic contraction in tail artery from hypertensive rats, Cardiovasc. Res., 45, 463, 10.1016/S0008-6363(99)00279-5

Gonon, 2000, Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production, J. Cardiovasc. Pharmacol., 36, 405, 10.1097/00005344-200009000-00018

Gossl, 2004, Endothelin-B-receptor-selective antagonist inhibits endothelin-1 induced potentiation on the vasoconstriction to noradrenaline and angiotensin II, J. Hypertens., 22, 1909, 10.1097/00004872-200410000-00013

Hempelmann, 1999, Threshold concentrations of endothelin-1: the effects on contractions induced by 5-hydroxytryptamine in isolated rat and cerebral and mesenteric arteries, Pharmacol. Toxicol., 85, 115, 10.1111/j.1600-0773.1999.tb00077.x

Henrion, 1993, Potentiation of norepinephrine-induced contractions by endothelin-1 in the rabbit aorta, Hypertension, 22, 78, 10.1161/01.HYP.22.1.78

Nakayama, 1991, Potentiation by endothelin-1 of 5-hydroxytryptamine-induced contraction in coronary artery of the pig, Br. J. Pharmacol., 104, 978, 10.1111/j.1476-5381.1991.tb12536.x

Obara, 1999, Contractile potentiation by endothelin-1 involves protein kinase C-delta activity in the porcine coronary artery, Jpn. J. Physiol., 49, 175, 10.2170/jjphysiol.49.175

Padilla, 1997, Peptidergic modulation of the sympathetic contraction in the rabbit ear artery: effects of temperature, Br. J. Pharmacol., 121, 21, 10.1038/sj.bjp.0701094

Pernow, 1997, Endothelin in myocardial ischemia and reperfusion, Cardiovasc. Res., 33, 518, 10.1016/S0008-6363(96)00265-9

Saldeen, 1993, Increased production of thromboxane A2 by coronary arteries after thrombolysis, Am. Heart J., 125, 277, 10.1016/0002-8703(93)90001-P

Sanz, 2003, Effects of diabetes on the vascular response to nitric oxide and constrictor prostanoids: gender and regional differences, Life Sci., 72, 1537, 10.1016/S0024-3205(02)02444-X

Thompson, 1995, Responses to endothelins-1, -2, and -3 and sarafotoxin 6c after ischemia/reperfusion in isolated perfused rat heart: role of vasodilator loss, J. Cardiovasc. Pharmacol., 25, 156, 10.1097/00005344-199501000-00024

Toyo-oka, 1991, Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris, Circulation, 83, 701, 10.1161/01.CIR.83.2.476

Vitola, 1996, Role of endothelin in a rabbit model of acute myocardial infarction: effects of receptor antagonists, J. Cardiovasc. Pharmacol., 28, 774, 10.1097/00005344-199612000-00007

Wang, 1995, Myocardial release of endothelin (ET) and enhanced ETA receptor-mediated coronary vasoconstriction after coronary thrombosis and thrombolysis in pigs, J. Cardiovasc. Pharmacol., 26, 770, 10.1097/00005344-199511000-00014

Wang, 2002, Pharmacological possibilities for protection against myocardial reperfusion injury, Cardiovasc. Res., 55, 25, 10.1016/S0008-6363(02)00261-4

Watts, 1992, Effects of nosoldipine upon vasoconstrictor responses and binding of endothelin-1 in ischemic and reperfused rat hearts, J. Cardiovasc. Pharmacol., 19, 929, 10.1097/00005344-199206000-00014

Yang, 1990, Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?, Circulation, 82, 188, 10.1161/01.CIR.82.1.188

Zerrouk, 1997, Role of endothelium in the endothelin-1 mediated potentiation of the norepinephrine response in the aorta of hypertensive rats, J. Hypertens., 5, 1101, 10.1097/00004872-199715100-00008